卵巢子宫内膜异位症患者接受IVF/ICSI时卵母细胞质量的间接标志物:系统评价与荟萃分析
该系统评价与荟萃分析纳入31项研究,比较卵巢子宫内膜异位症(OMA)患者与无卵巢解剖或功能异常女性在IVF/ICSI中的卵母细胞质量间接标志物。OMA组获卵总数和成熟(MII)卵母细胞数及优质胚胎数显著减少,但受精率、囊胚形成率和周期取消率无显著差异。作者认为OMA可能降低获卵数,但似乎不损害卵母细胞质量。
要点
- OMA患者获卵总数和成熟(MII)卵母细胞数显著低于无卵巢异常女性。
- OMA患者优质胚胎数显著减少,但受精率、囊胚形成率无显著差异。
- 卵巢敏感指数两组相似,现有数据不足以荟萃分析整倍体率。
核心结论
- OMA可能降低IVF/ICSI患者的获卵数,但似乎不损害卵母细胞质量。
研究设计与样本
- 系统评价与荟萃分析,检索MEDLINE、Cochrane对照试验注册库和ClinicalTrials.gov截至2023年10月的随机对照试验、病例对照研究和队列研究,纳入31项研究。
主要发现
- 受精率OR 1.10(95%CI 0.94-1.30)、囊胚形成率OR 0.86(95%CI 0.64-1.14)、周期取消率OR 1.06(95%CI 0.78-1.44),均无显著差异。
- 获卵总数均数差-1.59(95%CI -2.25至-0.94),成熟(MII)卵母细胞数均数差-1.86(95%CI -2.46至-1.26),OMA组均显著低于对照组。
- 优质胚胎数均数差-0.49(95%CI -0.92至-0.06),OMA组显著低于对照组。
- 卵巢敏感指数均数差-1.55(95%CI -3.27至0.18),两组相似。
- 现有数据缺乏,未能对整倍体率进行荟萃分析。
关键数值与推荐
- OMA组获卵总数较对照组平均少1.59个(95%CI -2.25至-0.94)。
- OMA组成熟(MII)卵母细胞数较对照组平均少1.86个(95%CI -2.46至-1.26)。
- OMA组优质胚胎数较对照组平均少0.49个(95%CI -0.92至-0.06)。
- 受精率OR 1.10(95%CI 0.94-1.30),囊胚形成率OR 0.86(95%CI 0.64-1.14),周期取消率OR 1.06(95%CI 0.78-1.44)。
- 卵巢敏感指数均数差-1.55(95%CI -3.27至0.18)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 现有发表数据缺乏,未能对整倍体率进行荟萃分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This systematic review and meta-analysis aimed to evaluate the impact of ovarian endometriomas (OMA) on indirect markers of oocyte quality in patients undergoing IVF, compared with women without anatomical or functional ovarian abnormalities. The search spanned original randomized controlled trials, case-control studies and cohort studies published in MEDLINE, the Cochrane Controlled Trials Register and the ClinicalTrials.gov database up to October 2023. Thirty-one studies were included in the meta-analysis, showing no significant differences in fertilization (OR 1.10, 95% CI 0.94-1.30), blastulation (OR 0.86, 95% CI 0.64-1.14) and cancellation (OR 1.06, 95% CI 0.78-1.44) rates. However, patients with OMA exhibited significantly lower numbers of total and mature (metaphase II) oocytes retrieved (mean difference -1.59, 95% CI -2.25 to -0.94; mean difference -1.86, 95% CI -2.46 to -1.26, respectively), and lower numbers of top-quality embryos (mean difference -0.49, 95% CI -0.92 to -0.06). The Ovarian Sensitivity Index was similar between the groups (mean difference -1.55, 95% CI -3.27 to 0.18). The lack of data published to date prevented meta-analysis on euploidy rate. In conclusion, although the presence of OMA could decrease the oocyte yield in patients undergoing IVF/intracytoplasmic sperm injection, it does not appear to have an adverse impact on oocyte quality.
引用
- Gayete-Lafuente S, Vilà Famada A, Albayrak N, et al. Indirect markers of oocyte quality in patients with ovarian endometriosis undergoing IVF/ICSI: a systematic review and meta-analysis. Reprod Biomed Online. 2024. PMID: 38943812. doi:10.1016/j.rbmo.2024.104075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。